Microbiology Spectrum · 2023 · 16 citations · 26 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyAdult ImmunizationAntibody CharacterizationPreclinical Vaccine EvaluationVaccinationVaccine TypesAntibodiesBooster Vaccine ImmunogenicityMultivalent VaccinesNeutralizing Antibody ResponsesReceptor Binding Domain VaccinesSars-cov-2 InfectionSerologic Response To Booster VaccinationVaccine-induced Antibody Responses
Although Omicron BA.1-containing bivalent vaccines have been authorized, real-world data validating their safety and antibody responses remain scarce. We conducted a prospective longitudinal study to assess the safety, immunogenicity, and reactogenicity of the second booster dose with the Omicron BA.1 bivalent vaccine in health care workers. Compared with the original monovalent vaccine, the bivalent (WT+BA.1) vaccine elicited higher levels of neutralizing antibodies against the Omicron BA.2 and BA.5 subvariants. The frequency of adverse events after the second booster dose was similar to that of the monovalent vaccine. BA.5-neutralizing antibodies induced by the bivalent Omicron BA.1-containing vaccine were expected to decline. A prospective longitudinal study should be performed to determine the persistence of the humoral immunity.
26
A global database of COVID-19 vaccinations
Edouard Mathieu, Hannah Ritchie, Esteban Ortiz-Ospina et al. · Nature Human Behaviour · 2021 · 2.1K citations · Full text
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Yunlong Cao, Ayijiang Yisimayi, Fanchong Jian et al. · Nature · 2022 · 1.4K citations · Full text
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
Qian Wang, Yicheng Guo, Sho Iketani et al. · Nature · 2022 · 844 citations · Full text